ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質(癌免疫療法用)

ACROBiosystems社 プロダクトリスト:Recombinant Protein

サプライヤー
AcroBioSystems
カタログNo.
TFI-C52H3
製品名称
Rhesus macaque TFPI Protein
タンパク質名
TFPI
Species
Rhesus macaque
HOST
HEK293
50ug: 66,000円
お問い合わせ
1mg: 441,000円
お問い合わせ

Overview

Synonyms TFPI,LACI,TFPI1,EPI,TFI
Characteristics This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 31.1 kDa. The protein migrates as 41-45 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin Level Less than 1.0 EU per μg by the LAL method.
Purity >95% as determined by SDS-PAGE.
Description Tissue factor pathway inhibitor (TFPI) is also known as Extrinsic pathway inhibitor (EPI), Lipoprotein - associated coagulation inhibitor (LACI), is a plasma proteinase inhibitor synthesized by vascular endothelial cells and part of it is associated with glycosaminoglycans of these cells. TFPI is a single-chain polypeptide which can reversibly inhibit Factor Xa (Xa) and Thrombin (Factor IIa). TFPI is a secreted protein with a N?terminal acidic region, three Kunitz (K) domains separated with by two linker regions, and a C?terminal basic region. The first K domain inhibits coagulation factor VIIa complexed to tissue factor (TF); The second K domain inhibits factor Xa; The third K domain binds to heparin; The C?terminal basic region may have several functions. For example, it plays an important role in binding of TFPI to cell surfaces.
Reference (1) Bajaj MS., et al., 2001, Thromb Haemost., 86:959.
(2) Mine S., et al., 2002, Biochemistry, 41:78.
(3) Witt I., et al., 2002, Hamostaseologie, 22:30?35.
URL http://www.acrobiosystems.com/P1747-Rhesus-Macaque-TFPI-Protein.html

お問い合わせリスト(-)

お問い合わせフォーム